Kansas Cancer Center honors two Indian American doctors
Priyanka Sharma and Prateek Sharma invested with endowed professorships recognizing center’s most productive faculty
Two distinguished Indian American members of The University of Kansas Cancer Center have been formally invested with endowed professorships recognizing the cancer center’s most productive faculty.
Priyanka Sharma and Prateek Sharma were honored at an investiture ceremony on March 21, according to a press release.
Read: Kerala Center honors six outstanding achievers (November 26, 2021)
Priyanka Sharma, MD, professor in the Department of Medical Oncology at the University of Kansas School of Medicine and co-leader of the cancer center’s Drug Discovery, Delivery and Experimental Therapeutics research program, was invested with the Frank B. Tyler Cancer Research Professorship – A.
A breast medical oncologist, Dr Priyanka Sharma is a leading expert on triple-negative breast cancer. She has dedicated much of her career to identifying more effective therapies to treat this aggressive subtype of breast cancer.
Dr Priyanka Sharma serves as vice chair for the breast committee of SWOG and is a member of the SWOG Board of Governors and National Cancer Institute (NCI) breast cancer steering committee.
Prateek Sharma, MD, professor of medicine and director of GI Fellowship Training at the University of Kansas School of Medicine, was invested with the Elaine Blaylock Cancer Research Professorship.
Dr Prateek Sharma is a renowned gastroenterologist and scientist focusing on esophageal diseases, including cancer. Currently, he is president-elect of the American Society for Gastrointestinal Endoscopy, serves as chair on the Esophageal Committee of World Endoscopy Organization and chairs the American Society for Gastrointestinal Endoscopy artificial intelligence task force.
Both professorships are appointed positions made by Roy Jensen, MD, vice chancellor and director of The University of Kansas Cancer Center.
“Drs Priyanka and Prateek Sharma are outstanding leaders and experts in their respective fields,” Dr. Jensen said. “Through these endowed chairs, both can pursue more innovative ideas and create more interdisciplinary collaborations leading to advances in cancer care.”
The University of Kansas Cancer Center is the only National Cancer Institute-designated comprehensive cancer center in the region, and one of only 53 in the nation, to receive this elite distinction.
Comprehensive designation is the highest level of recognition awarded by the NCI. NCI-designated cancer centers are recognized for their scientific excellence, including their depth and breadth of research.
